癌神経科学における臨床試験設計における新しいアプローチ
Gregory Jones1, Jennifer L Anderson2, Phuong T T Nguyen3
1Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Neuron
|September 4, 2025
まとめ
癌の神経科学は 新しい治療法のために 脳と癌の細胞のコミュニケーションを 探求しています このレビューでは,これらの発見を有効ながん治療法に変換する際の課題を克服するために,薬物の再利用と最適化された試験を強調しています.
科学分野:
- 癌 神経科学
- 神経腫瘍学
- 翻訳的ながん研究
背景:
- がん神経科学の新分野は 神経系と癌細胞の双方向的なコミュニケーションを明らかにしています
- 様々な悪性腫瘍の新たな治療的脆弱性を特定する.
- これらの基本的な洞察を臨床応用に移すには 大きな課題があります
研究 の 目的:
- 癌神経科学の発見を効果的な治療法に変換するための課題と戦略を検討する.
- 薬物の再利用,バイオマーカーの開発,最適化された臨床試験設計を含む革新的なアプローチを提案する.
- 神経信号伝達経路の潜在的治療標的を 強調するためです
主な方法:
- 癌神経科学と治療翻訳に関する既存の文献のレビュー
- 神経活性剤に焦点を当てた薬物再利用戦略の分析
- マスター・プロトコルとウィンドウ・オブ・オプortunity試験を含む最適化された臨床試験設計の議論.
主要な成果:
- グルタマタージック,アドレナージック,ニューロトロフィック経路を標的にする神経活性剤の薬物再利用は,治療の加速経路を提供します.
- "二重使用"特性 (毒性の軽減と抗腫瘍効果) を有する再利用剤の可能性を特定した.
- マスター・プロトコルとウィンドウ・オブ・チャンス・試験は,メカニズムと患者中心の結果の迅速な検証を容易にする.
結論:
- 癌神経科学の洞察を臨床的進歩に変換するには 体系的で学際的なアプローチが不可欠です
- 神経毒性の軽減と 患者の生活の質の改善に重点を置くことが重要です
- 癌神経科学は 治療に抵抗する癌の 新種の治療法を開発する上で 重要な可能性を秘めています
さらに関連する動画
関連する概念動画
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.5K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
Study Designs in Epidemiology
408
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
408


